YOJEMTU Trademark

Trademark Overview


On Tuesday, March 4, 2025, a trademark application was filed for YOJEMTU with the United States Patent and Trademark Office. The USPTO has given the YOJEMTU trademark a serial number of 79422222. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 27, 2025. This trademark is owned by Synox Therapeutics UK Limited. The YOJEMTU trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for the treatment of cancer and non-cancer fibrotic and inflammatory diseases for medical purposes; monoclonal antibodies for medical use; pharmaceutical preparations for the prevention, diagnosis and treatment of cancer and immune-mediated inflammatory and autoimmune diseases, namely tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft-tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma; diagnostic reagents for medical purposes for use in connection with tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, gl...

Scientific and medical research; pharmaceutical research and development; drug discovery services; pharmaceutical product development; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; clinical scientific research in the fields of oncology and immunology; providing medical and scientific research information in the fields of oncology and immunology; design and development of pharmaceutical preparations and medicines
yojemtu

General Information


Serial Number79422222
Word MarkYOJEMTU
Filing DateTuesday, March 4, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, October 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for the treatment of cancer and non-cancer fibrotic and inflammatory diseases for medical purposes; monoclonal antibodies for medical use; pharmaceutical preparations for the prevention, diagnosis and treatment of cancer and immune-mediated inflammatory and autoimmune diseases, namely tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft-tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma; diagnostic reagents for medical purposes for use in connection with tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma
Goods and ServicesScientific and medical research; pharmaceutical research and development; drug discovery services; pharmaceutical product development; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; clinical scientific research in the fields of oncology and immunology; providing medical and scientific research information in the fields of oncology and immunology; design and development of pharmaceutical preparations and medicines
Translation of Words in MarkThe wording YOJEMTU has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 24, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSynox Therapeutics UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 24, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 28, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, August 5, 2025ASSIGNED TO EXAMINER
Wednesday, August 6, 2025NON-FINAL ACTION WRITTEN
Thursday, August 7, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 16, 2025REFUSAL PROCESSED BY MPU
Wednesday, September 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 3, 2025REFUSAL PROCESSED BY IB
Thursday, October 9, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 9, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 16, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, October 16, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, October 16, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 16, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, October 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER